Pregnant

Description: 
This consent form -- reproduced with permission from the Boston Medical Center -- can be used with your pregnant patients who want to continue taking buprenorphine during pregnancy.
Source: 
Boston Medical Center
4
Your rating: None Average: 4 (1 vote)
Description: 
Presently, methadone is the recommended treatment for opioid-dependent pregnant women, but is associated with neonatal abstinence syndrome (NAS). NAS is characterized by opioid withdrawal symptoms in the newborn, which often requires longer hospitalization and treatment. Buprenorphine, FDA-approved in 2002 for the treatment of opioid dependence in non-pregnant individuals, hasn't been extensively studied during pregnancy. Yet, a new study in the New England Journal of Medicine (NEJM) found that buprenorphine offers an alternative to methadone in the treatment of opioid-dependent pregnant women. The study compared buprenorphine to methadone in 131 mothers and their newborns at eight international sites.
Source: 
New England Journal of Medicine
0
Your rating: None
Description: 
This guideline offers guidelines on treating pregnant, substance-using women, with sections on Alcohol and Other Drug Treatment Guidelines for Pregnant, Substance-Using Women, Medical Guidelines for Pregnant, Substance-Using Women, and Legal and Ethical Guidelines for the Care of Pregnant, Substance-Using Women.
Source: 
U.S Department of Health and Human Services
0
Your rating: None
Description: 
This guide contains information for health care providers on the problem of drug-exposed infants and their families. Topics covered include medical management, followup and aftercare, psychosocial services, ethical and legal guidelines, and quality assurance.
Source: 
Center for Substance Abuse Treatment (CSAT)
0
Your rating: None
Description: 
This 2005 randomized controlled study examined transitioning women from short-acting opioids to buprenorphine with respect to safety and withdrawal discomfort.
Source: 
Drug and Alcohol Dependence
3.75
Your rating: None Average: 3.8 (4 votes)
Description: 
This website, funded by SAMHSA, is designed to help physicians to implement office-based buprenorphine treatment using a national network of trained physician mentors.
Source: 
Physician Clinical Support System (PCSS)
5
Your rating: None Average: 5 (2 votes)
Description: 
This website offers comprehensive guidelines for treating patients who have substance use disorders.
Source: 
American Psychiatric Association (APA), 2006
4.25
Your rating: None Average: 4.3 (4 votes)
Description: 
Four-page document discussing treatment of pregnant patients with buprenorphine.
Source: 
Physician Clinical Support System (PCSS)
4.666665
Your rating: None Average: 4.7 (3 votes)
Description: 
This consent form informs the patient of the limited amount of research and knowledge currently available regarding buprenorphine use during pregnancy, and acknowledges that risks related to such use may exist, but are not yet known.
Source: 
Colleen LaBelle, RN/Boston Medical Center
4.333335
Your rating: None Average: 4.3 (3 votes)
Syndicate content